Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$3,505,351
+$314,178 QoQ
Shares Held
27,279
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#1,241
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. MRK ranks #5 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,527 | $7,498,972 | |
| 2 | ABBV |
AbbVie Inc.
|
24,774 | $6,234,129 | |
| 3 | AMGN |
Amgen Inc
|
11,880 | $4,301,985 | |
| 4 | LLY |
ELI LILLY & Co
|
3,556 | $4,265,173 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
27,279 | $3,505,351 | |
| 6 | AZN |
Astrazeneca PLC
|
15,893 | $3,013,630 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
21,070 | $2,661,983 | |
| 8 | PFE |
Pfizer Inc
|
21,427 | $515,962 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,505,351 | 27,279 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,191,173 | 26,529 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,077,591 | 29,238 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,812,552 | 21,596 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,773,579 | 22,405 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,248,936 | 25,055 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,403,436 | 24,160 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,696,255 | 23,743 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,267,768 | 18,318 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,084,678 | 15,799 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,670,622 | 15,324 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,639,375 | 15,924 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,883,626 | 16,324 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $1,752,562 | 16,473 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $3,091,843 | 27,867 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,700,637 | 31,359 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $2,683,497 | 29,434 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,181,299 | 26,585 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,069,969 | 27,009 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $2,100,676 | 27,968 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,178,959 | 28,018 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $2,453,082 | 31,821 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $2,405,573 | 29,408 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $2,440,556 | 29,422 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,711,964 | 35,070 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,017,365 | 26,220 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||